Suppr超能文献

百日咳疫苗接种后的免疫持久性。

Immune persistence after pertussis vaccination.

作者信息

Chen Zhiyun, He Qiushui

机构信息

a Department of Medical Microbiology and Research Centre of Microbiome , Capital Medical University , Beijing , China.

b Department of Medical Microbiology and Immunology , University of Turku , Turku , Finland.

出版信息

Hum Vaccin Immunother. 2017 Apr 3;13(4):744-756. doi: 10.1080/21645515.2016.1259780. Epub 2017 Jan 3.

Abstract

Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true infection rate is significantly higher than the reported incidence rate. An increased prevalence of pertussis in older populations has been found, mainly caused by waning immunity after vaccination. Vaccine-induced immunity differs due to variation in vaccine content, schedule and coverage. Protection following acellular pertussis vaccines has been suggested to wane faster than whole cell pertussis vaccines. However, long-term immune persistence of whole cell pertussis vaccines may be confounded by a progressive acquisition of natural immunity. The World Health Organization has recommended that a switch from whole cell to acellular pertussis vaccines for primary immunization in infants should only be considered if additional periodic boosters or maternal immunization can be ensured and sustained in the national immunization schedules. In this review, we present data on immune persistence after different pertussis vaccinations and compare the findings from countries with different vaccination strategies. Future aspects in serological studies are briefly discussed.

摘要

百日咳是全球最常见的可通过疫苗预防的疾病之一。实际感染率显著高于报告发病率。已发现老年人群中百日咳患病率增加,主要原因是疫苗接种后免疫力下降。由于疫苗成分、接种程序和覆盖率的差异,疫苗诱导的免疫力也有所不同。有人认为,无细胞百日咳疫苗诱导的保护作用比全细胞百日咳疫苗消退得更快。然而,全细胞百日咳疫苗的长期免疫持久性可能会因自然免疫力的逐步获得而受到混淆。世界卫生组织建议,只有在国家免疫规划中能够确保并持续进行额外的定期加强免疫或母体免疫时,才应考虑在婴儿的初次免疫中从全细胞百日咳疫苗转向无细胞百日咳疫苗。在本综述中,我们展示了不同百日咳疫苗接种后的免疫持久性数据,并比较了采用不同疫苗接种策略的国家的研究结果。还简要讨论了血清学研究的未来方向。

相似文献

1
Immune persistence after pertussis vaccination.
Hum Vaccin Immunother. 2017 Apr 3;13(4):744-756. doi: 10.1080/21645515.2016.1259780. Epub 2017 Jan 3.
2
Roads to the development of improved pertussis vaccines paved by immunology.
Pathog Dis. 2015 Nov;73(8):ftv067. doi: 10.1093/femspd/ftv067. Epub 2015 Sep 6.
4
Immune responses to pertussis vaccines and disease.
J Infect Dis. 2014 Apr 1;209 Suppl 1:S10-5. doi: 10.1093/infdis/jit560. Epub 2013 Oct 31.
5
Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection.
Expert Rev Vaccines. 2015;14(8):1065-72. doi: 10.1586/14760584.2015.1059759. Epub 2015 Jun 22.
6
Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
Vaccine. 2018 Jan 4;36(2):220-226. doi: 10.1016/j.vaccine.2017.11.066. Epub 2017 Dec 1.
7
Prevention of pertussis: An unresolved problem.
Hum Vaccin Immunother. 2018;14(10):2452-2459. doi: 10.1080/21645515.2018.1480298. Epub 2018 Jul 24.
8
Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.
Vaccine. 2015 Sep 22;33(39):5027-30. doi: 10.1016/j.vaccine.2015.08.021. Epub 2015 Aug 19.
9
Pertussis: Where did we go wrong and what can we do about it?
J Infect. 2016 Jul 5;72 Suppl:S34-40. doi: 10.1016/j.jinf.2016.04.020. Epub 2016 May 6.
10
Licensed pertussis vaccines in the United States. History and current state.
Hum Vaccin Immunother. 2014;10(9):2684-90. doi: 10.4161/hv.29576. Epub 2014 Nov 6.

引用本文的文献

1
Resurgence of pertussis: whopping the '100-day cough'.
Curr Opin Pediatr. 2025 Oct 1;37(5):508-516. doi: 10.1097/MOP.0000000000001486. Epub 2025 Aug 21.
2
Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance.
Hum Vaccin Immunother. 2025 Dec;21(1):2513729. doi: 10.1080/21645515.2025.2513729. Epub 2025 Jun 9.
3
Seroepidemiological Assessment of in Jahrom, Southern Iran: A Cross-Sectional Study.
Health Care Sci. 2025 Feb 17;4(1):44-51. doi: 10.1002/hcs2.70000. eCollection 2025 Feb.
4
Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.
Expert Rev Vaccines. 2024 Jan-Dec;23(1):705-714. doi: 10.1080/14760584.2024.2383745. Epub 2024 Jul 24.
5
Public health management of pertussis in adults: Practical challenges and future strategies.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2377904. doi: 10.1080/21645515.2024.2377904. Epub 2024 Jul 17.
6
Pertussis Epidemiology in the Autonomous Province of Vojvodina, Serbia, 1948-2023.
Vaccines (Basel). 2024 May 10;12(5):525. doi: 10.3390/vaccines12050525.
7
Serological responses to immunization during nephrosis in infants with congenital nephrotic syndrome of the Finnish type.
Front Pediatr. 2024 May 2;12:1392873. doi: 10.3389/fped.2024.1392873. eCollection 2024.
10
T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination.
Cell Host Microbe. 2023 Aug 9;31(8):1404-1416.e4. doi: 10.1016/j.chom.2023.06.015. Epub 2023 Jul 24.

本文引用的文献

1
The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children.
Vaccine. 2016 Jul 29;34(35):4221-4228. doi: 10.1016/j.vaccine.2016.06.051. Epub 2016 Jun 28.
2
Pertussis vaccination during pregnancy: Antibody persistence in infants.
Vaccine. 2016 Jul 19;34(33):3719-22. doi: 10.1016/j.vaccine.2016.05.051. Epub 2016 Jun 11.
3
Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.
PLoS One. 2016 Jun 3;11(6):e0155949. doi: 10.1371/journal.pone.0155949. eCollection 2016.
4
Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China.
PLoS One. 2016 May 25;11(5):e0155965. doi: 10.1371/journal.pone.0155965. eCollection 2016.
5
Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years.
J Infect. 2016 Jul;73(1):38-44. doi: 10.1016/j.jinf.2016.04.004. Epub 2016 Apr 8.
7
Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence.
Infect Genet Evol. 2016 Jun;40:136-143. doi: 10.1016/j.meegid.2016.02.032. Epub 2016 Feb 27.
9
Adult pertussis is unrecognized public health problem in Thailand.
BMC Infect Dis. 2016 Jan 25;16:25. doi: 10.1186/s12879-016-1357-x.
10
Pertussis specific cell-mediated immune responses ten years after acellular pertussis booster vaccination in young adults.
Vaccine. 2016 Jan 12;34(3):341-9. doi: 10.1016/j.vaccine.2015.11.049. Epub 2015 Nov 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验